Latest News about AXLA
Recent news which mentions AXLA
Earnings Scheduled For March 30, 2022
March 30, 2022
From Benzinga
From Benzinga
From Benzinga
Executives Buy Around $16M Of 4 Penny Stocks
March 21, 2022
From Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
From Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
March 17, 2022
From Benzinga
Insiders Buy Over $7M Of 3 Penny Stocks
March 17, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 07, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 25, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 21, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 08, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
64 Biggest Movers From Yesterday
October 28, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
From Benzinga
60 Biggest Movers From Yesterday
October 27, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Axcella's Leading Drug Candidate for Overt Hepatic Encephalopathy Offers Hope in a Market Requiring Innovation
September 28, 2021
Tickers
AXLA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
September 22, 2021
From Benzinga
Axcella's First-of-Its-Kind NASH Treatment Shows Promising Early Results in Human Trials
September 09, 2021
Tickers
AXLA
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 01, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.